Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00788619 · ClinicalTrials.gov registry record · NA
Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)
A NA study, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- NA
- Development phase
- 2
- Enrollment target
NCT00788619: Clinical Trial NA study, sponsored by Johns Hopkins University.
NCT00788619 is a NA study that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 2 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00788619, a NA study, was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2 participants
- Enrollment target
Study Summary
Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of multiple pregnancy with associated maternal and neonatal morbidity and mortality. The investigators believe that the concentration of nitric oxide metabolites measured in the culture medium from the first day of culture can identify the best quality embryos allowing us to transfer a limited number of embryos without compromising the optimum chance for pregnancy.
Interventions
- PROCEDURE Transfer of embryos on day 3 or day 5 after fertilization.
- PROCEDURE Day 5 transfer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00788619
The ClinicalTrials.gov registry entry for NCT00788619 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 2 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transfer of embryos on day 3 or day 5 after fertilization. is the first listed.
NCT00788619 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00788619 about?
NCT00788619 is a clinical study titled "Use of Nitric Oxide Metabolites for Predicting Embryo Quality in In-Vitro Fertilization (IVF)". Improvements in In-Vitro Fertilization (IVF) outcomes have largely been due to the generation of excess embryos allowing for multiple embryo transfer. Unfortunately this has also increased the risk of multiple pregnancy with associated maternal and neonatal morbidity and mortality. The investigators...
What is the current status of trial NCT00788619?
This trial is currently terminated. It is a NA study. The enrollment target is 2 participants. The study started on 2009-01. Estimated completion is 2009-10.
What interventions are being tested in trial NCT00788619?
The interventions under investigation include: Transfer of embryos on day 3 or day 5 after fertilization. (PROCEDURE), Day 5 transfer (PROCEDURE).
Who is sponsoring clinical trial NCT00788619?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.